Biotech and Life Sciences

We serve more than 100 biotech and life sciences companies across pharmaceuticals, biotechnology, medical devices, nutraceuticals, CROs, CMOs, and other innovative healthcare sectors. From startup through commercialization and the public markets, we help you navigate the financial, regulatory, and operational complexities that come with growth.

• Lifecycle-specific financial guidance: Every stage of your company’s lifecycle brings new financial priorities. From establishing your accounting infrastructure in the early stages to preparing for a capital raise, IPO, or M&A transaction, our team provides practical guidance tailored to where your business is today — and where you’re headed next.
• Technical accounting and reporting you can rely on: Revenue recognition, R&D cost capitalization, equity accounting, and public company reporting all require technical precision. We help you navigate complex accounting requirements while delivering accurate, reliable financial reporting that supports investors, lenders, and other stakeholders.
• Tax credit planning: Biotech and life sciences companies often qualify for federal R&D tax credits, orphan drug tax credits, and other incentives. We help you identify eligible activities, document qualified expenses, and claim all available credits so you can reinvest more capital into innovation.
• Capital and transaction readiness: Whether you’re preparing for your next funding round, planning an IPO, or exploring M&A, we help position your business for success with investor-ready financial reporting, stronger internal controls, transaction advisory, valuation services, and due diligence support.